We confirmed this in bladder cancer cells by demonstrating that CsA and FK506 reduced the overall and nuclear levels of NFATc1 expression, suppressed the transcriptional activity of NFAT, and down-regulated the expression of COX-2 and c-myc. The gene discussed is NFATC1; the disease is urinary bladder carcinoma.